# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Truist Securities analyst Richard Newitter maintains Integra Lifesciences (NASDAQ:IART) with a Hold and raises the price tar...
Morgan Stanley analyst Drew Ranieri maintains Integra Lifesciences (NASDAQ:IART) with a Underweight and raises the price tar...
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, is announcing its plans t...
Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Neutral and raises the price target fro...
Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Neutral and raises the price target fro...
Morgan Stanley analyst Drew Ranieri maintains Integra Lifesciences (NASDAQ:IART) with a Underweight and lowers the price tar...